Panel Discussion: What Is the Role of Medical Affairs in the Launch of a Gene Therapy

Time: 10:40 am
day: Day Two


  • How can medical affairs prepare the market for an imminent launch beyond reactive responses?
  • How should medical affairs promote the distinctive features of a clinical program?
  • How do you keep KOL’s engaged and the gene therapy front of mind in a complaint manner?